Biogen (BIIB) Treasury Shares (2009 - 2026)

Biogen has reported Treasury Shares for 18 years, with the latest figure at $3.0 billion in Q2 2026.

• On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $3.0 billion in Q2 2026; TTM through Jun 2026 was $3.0 billion, a 0.0% change from a year earlier, with the FY2025 full-year figure at $3.0 billion, changed 0.0% from the prior year.
• Treasury Shares was $3.0 billion for Q2 2026 at Biogen, roughly flat from $3.0 billion in the prior quarter.
• The five-year high for Treasury Shares was $23.8 million in Q4 2022, with the low at -$23.8 million in Q1 2022.
• Average Treasury Shares over 5 years is -$13.2 million, with a median of -$23.8 million recorded in 2022.
• The largest YoY upside for Treasury Shares was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Over 5 years, Treasury Shares stood at $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
• The last three Treasury Shares figures came in at $3.0 billion (Q2 2026), $3.0 billion (Q1 2026), and $3.0 billion (Q4 2025), per Business Quant data.